NCT00945932View on ClinicalTrials.gov

A Study to Evaluate the Effect of Repeat Doses of GW870086X in Mild to Moderate Asthmatics

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Asthma
Interventions
DRUG

GW870086X

Investigational product

DRUG

Placebo

Placebo control

Trial Locations (8)

10367

GSK Investigational Site, Berlin

10717

GSK Investigational Site, Berlin

10787

GSK Investigational Site, Berlin

14057

GSK Investigational Site, Berlin

15562

GSK Investigational Site, Rüdersdorf

21502

GSK Investigational Site, Geesthacht

55131

GSK Investigational Site, Mainz

60596

GSK Investigational Site, Frankfurt am Main

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00945932 - A Study to Evaluate the Effect of Repeat Doses of GW870086X in Mild to Moderate Asthmatics | Biotech Hunter | Biotech Hunter